Paclitaxel Therapy in Peripheral Arterial Disease: Back to the Future?

JACC Cardiovasc Interv. 2022 Oct 24;15(20):2103-2104. doi: 10.1016/j.jcin.2022.08.048. Epub 2022 Sep 28.

Authors

Javier A Valle¹, Justin T Morrison²

Affiliations

¹ Michigan Heart and Vascular Institute, Ann Arbor, Michigan, USA. Electronic address: javier.valle@cuanschutz.edu.
² University of Colorado School of Medicine, Aurora, Colorado, USA.

PMID: 36265943
DOI: 10.1016/j.jcin.2022.08.048

No abstract available

Keywords: drug-coated balloon; paclitaxel; peripheral arterial disease.

Publication types

Editorial
Comment

MeSH terms

Angioplasty, Balloon*
Cardiovascular Agents* / adverse effects
Coated Materials, Biocompatible
Femoral Artery
Humans
Paclitaxel / adverse effects
Peripheral Arterial Disease* / diagnostic imaging
Peripheral Arterial Disease* / drug therapy
Popliteal Artery
Treatment Outcome

Substances

Paclitaxel
Coated Materials, Biocompatible
Cardiovascular Agents